Superparamagnetic Iron Oxide Nanoparticles: Promises for Diagnosis and Treatment of Multiple Sclerosis
- 4 February 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 2 (3) , 118-140
Abstract
Smart superparamagnetic iron oxide nanoparticles (SPIONs) are the most promising candidate for theragnosis (i.e., diagnosis and treatment) of multiple sclerosis. A deep understanding of the dynamics of the in vivo neuropathology of multiple sclerosis can be achieved by improving the efficiency of various medical techniques (e.g., positron emission tomography and magnetic resonance imaging) using multimodal SPIONs. In this Review, recent advances and challenges in the development of smart SPIONs for theragnostic applications are comprehensively described. In addition, critical outlines of emerging developments are provided from the points of view of both clinicians and nanotechnologists.Keywords
This publication has 197 references indexed in Scilit:
- Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicineJournal of Controlled Release, 2010
- An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxideAtherosclerosis, 2010
- Effects of nanomaterial physicochemical properties on in vivo toxicityAdvanced Drug Delivery Reviews, 2009
- Magnetic nanoparticles for theragnosticsAdvanced Drug Delivery Reviews, 2009
- In vitro assessments of nanomaterial toxicityAdvanced Drug Delivery Reviews, 2009
- Fluorescence Modified Chitosan-Coated Magnetic Nanoparticles for High-Efficient Cellular ImagingDiscover Nano, 2009
- Glyconanoparticles allow pre-symptomatic in vivo imaging of brain diseaseProceedings of the National Academy of Sciences, 2009
- Protein-passivated Fe3O4 nanoparticles: low toxicity and rapid heating for thermal therapyJournal of Materials Chemistry, 2008
- Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticlesThe FASEB Journal, 2007
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosisCochrane Database of Systematic Reviews, 2000